M01AX22 • morniflumat • Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Other antiinflammatory and antirheumatic agents, non-steroids
Morniflumatum is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain and inflammation associated with musculoskeletal conditions such as arthritis or sprains. It works by inhibiting prostaglandin synthesis, reducing inflammation and pain.
The medication is taken orally, usually in tablet form, and is indicated for short-term use. It is effective in relieving symptoms and improving mobility.
Side effects may include nausea, dyspepsia, abdominal pain, or, in rare cases, gastric ulcers or allergic reactions. It is important to follow the recommended dosage and avoid prolonged use without medical supervision.
Consult your doctor before use, especially if you have gastrointestinal conditions or are taking other medications. Use Morniflumatum as directed to avoid complications.
Substance: morniflumat
Date of last drug list: 01-07-2013
Commercial code: W04374002
Concentration: 400mg
Pharmaceutical form: suppositories
Quantity: 8
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.